VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
LearnAll lessons
Candlestick Patterns44 candles, each on two real charts
Pattern GuidesThe playbooks' setups on real breakouts
GlossaryInvesting terms in plain English
MinerviniVCP SetupsTrend Template
O'NeilCup with HandleFlat BaseDouble BottomCANSLIM Leaders
QullamaggieHigh Tight FlagsFlag BreakoutsEpisodic PivotsMomentum Leaders
KellWedge PopEMA Crossback
LivermorePivotal Points
PatternsFalling Wedge & ChannelBase Breakouts
View All Playbooks...
BreakoutsScanner
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
BreakoutsScanner
WatchlistPricing
Ctrl K
Pricing
HRMY
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Scanner
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsScannerWatchlist
HRMYHarmony Biosciences Holdings, Inc.
$32.96$1.9B
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
HomeStocksHRMYEarnings History

HRMY logoHarmony Biosciences Holdings, Inc. (HRMY) Earnings History

Profitable

8 years of earnings data (2018–2025) · Positive TTM net income

TTM Net Income
$179M
● Profitable
TTM EPS (Diluted)
$2.99
Per share, diluted
YoY EPS Growth
+8.0%
Solid
Net Margin
18.3%
After-tax profitability
EPS Growth Rate (CAGR)
1Y+8.0%
3Y-3.0%
5YN/A
10YN/A
Operating Margin24.0%
Gross Margin77.2%
Return on Equity20.8%
Return on Assets14.0%
Record Annual Net Income$181MFY2022
Record Quarterly EPS$1.44Q3 2022
Consecutive Profitable Years5years
Q3 2026
Net Income$48M
EPS (Diluted)$0.81
YoY Growth+8.0%Solid
QoQ Growth-36.1%Declining

Loading earnings history...

Harmony Biosciences Holdings, Inc. (HRMY) Earnings Overview

As of November 17, 2026, Harmony Biosciences Holdings, Inc. (HRMY) reported trailing twelve-month net income of $179M, reflecting +8.0% year-over-year growth. The company earned $2.99 per diluted share over the past four quarters, with a net profit margin of 18.3%.

Looking at the long-term picture, HRMY's historical earnings data spans multiple years. The company achieved its highest annual net income of $181M in fiscal 2022.

Harmony Biosciences Holdings, Inc. maintains industry-leading profitability with a gross margin of 77.2%, operating margin of 24.0%, and net margin of 18.3%. This margin structure demonstrates strong pricing power and operational efficiency. View revenue history →

Compared to peers including JAZZ ($206M net income, -8.3% margin), AVPT ($76M net income, 8.4% margin), AXSM (-$157M net income, -28.7% margin), HRMY has outperformed on profitability metrics. Compare HRMY vs JAZZ →

HRMY Earnings vs Peers

Earnings metrics vs comparable public companies

CompanyTTM Net IncomeTTM EPSNet MarginROEYoY GrowthCompare
HRMY logoHRMYCurrent
$179M$2.9918.3%20.8%+8.0%—
JAZZ logoJAZZ
$206M$3.18-8.3%-8.5%-167.5%
AVPT logoAVPT
$76M$0.348.4%9.4%+193.8%
AXSM logoAXSM
-$157M$-3.00-28.7%-252.1%+38.6%
INVA logoINVA
$193M$2.6863.8%29.1%+816.7%
SUPN logoSUPN
$450M$3.6916.9%-+10833.3%
Best in group
Lowest in group

HRMY Historical Earnings Data (2018–2025)

8 years
Fiscal Year Net Income YoY % Operating Income EPS (Diluted) Net Margin Op. Margin
2025$159M+9.1%$208M$2.7118.3%24.0%
2024$145M+12.9%$191M$2.5120.4%26.7%
2023$129M-29.0%$192M$2.1322.1%33.0%
2022$181M+424.5%$120M$2.9741.4%27.4%
2021$35M+193.6%$88M$0.5811.3%28.7%
2020-$37M+75.7%$17M$-1.10-23.1%10.6%
2019-$152M-280.9%-$146M$-2.94-2535.1%-2433.8%
2018-$40M--$41M$-1.42--

Download Data

Export HRMY earnings history in CSV or JSON format

Free sign-in required to download data

Consensus & Technical Research Suite
Open HRMY Terminal

HRMY Chart Terminal

WASM

Live VCP patterns, Cup & Handle overlays, support/resistance, and AI trade plans.

Launch Terminal

Live Breakouts Feed

LIVE

High-probability breakout stocks crossing their pivot across 5 pattern engines.

Explore Setups

Intrinsic Valuation

DCF models, multiple analysis, and analyst estimates.

Check Valuation

Historical Returns

8+ years return with dividends reinvested.

Calculate

Peer Comparison

Compare growth, multiples, and margins vs sector.

Compare

HRMY — Frequently Asked Questions

Quick answers to the most common questions about buying HRMY stock.

What is HRMY earnings per share (EPS)?

HRMY trailing twelve-month (TTM) diluted EPS is $2.99, reflecting +8.0% year-over-year growth. The 5-year EPS CAGR is N/A. Complete EPS history from 2018 to 2025 is available in the table on this page.

What is Harmony Biosciences Holdings, Inc.'s net income?

Harmony Biosciences Holdings, Inc. (HRMY) trailing twelve-month net income is $179M as of 2025. Earnings grew +8.0% year-over-year. Harmony Biosciences Holdings, Inc. has been profitable for 5 consecutive years.

Is HRMY profitable?

Yes, HRMY is profitable with a TTM net income of $179M and a net profit margin of +18.3%. Harmony Biosciences Holdings, Inc. has generated profits for 5 consecutive years.

What is HRMY's earnings growth rate?

HRMY compound annual EPS growth rates (CAGR): 1-Year: +8.0%, 3-Year: -3.0%, 5-Year: N/A, 10-Year: N/A. These figures measure the annualised rate of diluted EPS growth over each period, based on data from 2018 to 2025.

What are HRMY's profit margins?

Harmony Biosciences Holdings, Inc. net profit margin is +18.3%, operating margin is +24.0%, and gross margin is +77.2%. Above-average net margins reflect strong pricing power and competitive moat. Return on Equity is +20.8%.

Is HRMY growing earnings?

HRMY is growing earnings steadily. YoY EPS growth of +8.0% is consistent with the 5-year CAGR of N/A. TTM net income is $179M.

What was HRMY's best earnings year?

Harmony Biosciences Holdings, Inc.'s highest annual net income on record is $181M, achieved in fiscal year 2022. Earnings history on this page spans 2018 to 2025 and includes all annual and quarterly figures.

What were HRMY's earnings last quarter?

HRMY's most recent reported quarter was Q3 2026. Net income was $48M with diluted EPS of $0.81. For a full breakdown of all quarters, see the quarterly earnings table on this page.

HRMY Earnings Over Time (2018–2025)

Net income & EPS — annual and quarterly view